HUMA Earnings

HUMA reported its earnings on 2026-03-27, showcasing a revenue of against an estimate of 1.58M, resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.13 by 0%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following HUMA's earnings announcement on 2026-03-27, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, HUMA's stock price tends to shift by an average of 13.76% in the 10 days leading up to earnings and 8.89% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate HUMA's annual revenue to reach 1.34M, while the EPS is projected at -0.13. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between HUMA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, HUMA's stock price typically moves by 13.76% in the 10 days before its earnings and 8.89% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -0.13 and revenue of 1.34M.

The earnings call presents a positive outlook with strong financial improvements, reduced net loss, and promising trial data for Symvess, which is expected to drive future growth. The Q&A section highlights positive feedback from hospitals and surgeons, successful cost-saving measures, and strategic expansion plans. Despite some unclear responses, the overall sentiment is optimistic, supported by strong data and strategic initiatives, likely leading to a positive stock price movement.